Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a ...

A team of scientists has unveiled a gene-based diagnostic technology capable of detecting multi-drug-resistant bacteria and ...

SemperVirens, a venture fund investing in companies driving workforce transformation through innovation in the enterprise, healthcare and financial services sectors, today announced that it has closed ...